A shocking new study reveals that a condition that can lead to limb amputation is far more prevalent and deadly than ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million ...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a ...

Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

The treatment of many patients with peripheral artery disease is not optimal, and indeed is much worse than that in patients ...

Additional signs that might be mistaken for poor circulation include pins and needles sensations, coldness at the extremities ...

Shockwave Medical has commenced the IDE study of the Javelin Coronary IVL Catheter for treating calcified coronary lesions.

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes.